Literature DB >> 8573446

A 45-year follow-up of kindred 107 and the search for BRCA2.

D E Goldgar1, S L Neuhausen, L Steele, P Fields, J H Ward, T Tran, K Ngyuen, M R Stratton, D F Easton.   

Abstract

Interest in the genetics of breast cancer has intensified with the discovery of a breast cancer susceptibility locus, BRCA1, on chromosome 17q. In this paper, we describe updated information on a large breast cancer kindred (K107) that has been extensively studied since 1948. Specifically, we have identified many new cases of cancer in the family and have shown that this family is unlinked to BRCA1 as well as a number of other genes considered as candidates for breast cancer. In a collaborative study between the University of Utah and the Institute of Cancer Research in the United Kingdom, we have collected a set of families with a predisposition to breast and ovarian cancers that have been reliably excluded from linkage to BRCA1 and evaluated their usage in a genomic search for other breast cancer loci. This effort led to the discovery of a second breast cancer locus located on chromosome 13q, BRCA2, which is responsible for the increased incidence of breast cancer in Kindred 107.

Entities:  

Mesh:

Year:  1995        PMID: 8573446

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  6 in total

1.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

2.  ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

Authors:  Daria Fleyshman; Peter Cheney; Anda Ströse; Shaila Mudambi; Alfiya Safina; Mairead Commane; Andrei Purmal; Kelsey Morgan; Nicholas J Wang; Joe Gray; Paul T Spellman; Natalia Issaeva; Katerina Gurova
Journal:  Cell Cycle       Date:  2015-12-22       Impact factor: 4.534

3.  CD5 positive breast carcinoma in a patient with untreated chronic lymphocytic leukaemia: molecular studies of chromosome 13q.

Authors:  S Shousha; C Costello; Y A Luqmani; H D Sinnett
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

4.  Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b.

Authors:  Elena Mogilyansky; Peter Clark; Kevin Quann; Honglei Zhou; Eric Londin; Yi Jing; Isidore Rigoutsos
Journal:  Front Genet       Date:  2016-08-31       Impact factor: 4.599

Review 5.  The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.

Authors:  Mitsuhiro Nakamura; Takeshi Obata; Takiko Daikoku; Hiroshi Fujiwara
Journal:  Int J Mol Sci       Date:  2019-11-04       Impact factor: 5.923

6.  Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.

Authors:  Niklas Loman; Anna Bladström; Oskar Johannsson; Ake Borg; Håkan Olsson
Journal:  Breast Cancer Res       Date:  2003-08-07       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.